Alkermes’ Corporate Presentation to be Webcast at The NASDAQ OMX 31st Investor Program

DUBLIN--()--Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the NASDAQ OMX 31st Investor Program on Tuesday, Dec. 2, 2014, at 10:45 a.m. GMT (5:45 a.m. EST) from the Waldorf Hilton in London. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and manufacturing facilities in Gainesville, Georgia and Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.

Contacts

Alkermes
Eva Stroynowski, +1 781 609 6823
Corporate Communications

Contacts

Alkermes
Eva Stroynowski, +1 781 609 6823
Corporate Communications